Term
Parkinsonism causes and S/Ss |
|
Definition
- Parkinsonism includes tremors, rigidity, slow movement (bradykinesia), slurred speech, maskface, difficulty chewing/swallowing; unsteady gait with upper body bent forward
- Other conditions beside Parkinson’s disease can cause, though PD most common
- Drug adverse reactions can cuase parkinsonism reactions = extrapyramidal symptoms
|
|
|
Term
levodopa
levodopa with carbidopa
amantadine
bromocriptine
rasaglinine
selegiline |
|
Definition
dopaminergic drugs (increase dopamine in CNS)
rasaglinine and selegiline are MAOI dopaminergics (dopamine agonists) |
|
|
Term
Actions of dopaminergic drugs |
|
Definition
a. Increase dopamine (Parkinson's decrease in dopamine)
b. Only crosses B-B Barrier in small amounts
c. Carbidopa is only used with levodopa to increase levodopa absorption (no affect on own carbidopa)
d. levodopa is converted into dopamine
e. others work various mechanisms |
|
|
Term
Treatment and route ofr restless leg syndrome |
|
Definition
dopamine receptor agonists (other)
taken transdermally, not oral |
|
|
Term
Uses of dopiminergic drugs |
|
Definition
a. parkinson's
b. Extrapyramidal symptoms (parkinson's like)
c. Restless leg syndrome
d. viral infections |
|
|
Term
Adverse reactions to levodopa (and any levodpa combinations) |
|
Definition
- levodapa/carbidopa effect decreases over time
- dry mouth, difficulty swallowing
- ab pain constipation
- increased hand tremor
- headache and dizziness
- Most serious with levodapa are CHOREIFORM MOVEMENTS
- Less common are mental changes like dementia, depression, psychotic episodes, paranoia, suicidal tendencies
|
|
|
Term
|
Definition
- invol twitching of limbs or facial muscles, dystonic movements (spasms of tongue, jaw, eyes, neck usually)
- can be caused by levodopa/carbidopa admin
- If occurs, withhold and notify immediately
|
|
|
Term
Contraindications levodopa (and any levodopa combinations) |
|
Definition
i. narrow-angle glaucoma
ii. MAOIs
iii. can activate malignant melanoma |
|
|
Term
contraindications of MAOI dopamine agoists |
|
Definition
i. opioid meperidine (Demerol) bc of antimetabolite conversion |
|
|
Term
Precautions levodopa (or any levodopa combination) |
|
Definition
- CV or pulm disease
- peptic ulcers
- renal or hepatic disease
- psychosis
- pregnancy and lactation (cat C)
|
|
|
Term
Precautions MAOI dopamine agonists |
|
Definition
|
|
Term
1. benztropine
2. biperiden
3. diphenhydramine
4. procyclidine
5. trihexyphenidyl |
|
Definition
- cholinergic blocking (anticholinergic) drugs for treatment of parkinsonism
- are used for other conditions as well
|
|
|
Term
Actions/uses of anticholinergics for tx of parkinsonism |
|
Definition
- ACh is increased in Parkinson's, so drugs are used to block this to enhance dopamine transmission
- less effective than levodopa
- dosage limited by adverse reactions - diphenhydramine has least effects, best for elderly
- adjunct to all forms of parkinsonism
- control drug induced extrapyramidal effects
|
|
|
Term
Adverse reactions to anticholinergics |
|
Definition
- dry mouth
- blurred vision
- dizziness
- mild nausea
- nervousness
- rash, urticaria
- urinary retention, dysuria
- tachycardia
- muscle weakness
- disorientation, confusion
- >60 often have sensitivity to anticholinergics, require close monitor, esp. confusion and disorientation; may need lower doses
|
|
|
Term
Contraindications of anticholinergics |
|
Definition
- angle-closure glaucoma
- pyloric or duodenal obstruction
- peptic ulcers
- prostate hypertrophy
- achalasia (difficulty swallowing from lower esoph. muscles not relaxing)
- myesthenia gravis
- megacolon
|
|
|
Term
Precautions of anticholinergics |
|
Definition
- tachydardia
- cardiac arrhythmias
- hyper/hypo tension
- tendency towards urinary retention
- decreased liver or kidney function
- obstructive disease of GI tract
- older adults
Remember that anticholinergics are drying, which can reduce blood volume. This can increase heart rate to compensate. Therefore, caution with existing tachycardia, arrythmias, BP issues, inability to pee, kidneys/liver preexisting problem and need blood flow, GI stasis
AND OLDER ADULTS MORE SENSATIVE TO ALL |
|
|
Term
1. entacapone
2. tolcapone |
|
Definition
|
|
Term
Action and Uses of COMT inhibitors |
|
Definition
- prolong effect of levodopa by bloching the enzyme COMT (normally eliminates dopamine)
- increase plasma concentration and duration of action levodopa
|
|
|
Term
|
Definition
- adjunct to levodopa/carbidopa for Parkinson's
- Tolcapone reserves for those not responding to other treatments bc very hepatotoxic
- Entacapone less stong than tolcapone
|
|
|
Term
Adverse reactions to COMT inhibitors |
|
Definition
- dizziness
- dyskinesias, hyperkinesias
- nausea, anorexia, diarrhea
- orth hypo
- sleep disoreders, excessive dreaming, somnolence
- muscle cramps
- liver failure and death with tolcapone
|
|
|
Term
Contraindications of COMT inhibitors |
|
Definition
- pregnancy and lactation (cat C)
- Tolcapone contra in those with liver dysfunction
|
|
|
Term
Precautions of COMT inhibitors |
|
Definition
- hyper/hypo tension
- decreased renal and hepatic function (except tolcapone contraindication liver dysfunction)
|
|
|
Term
1. apomorphine
2. pramipexole
3. ropinirole |
|
Definition
- Non-ergot dopamine receptor agonists
- Not derived from ergot, which is a fungus
- Early dopamine agonists were ergot-derived (are not included in book)
|
|
|
Term
Actions of the non-ergot dopamine receptor agonists |
|
Definition
- not understood
- thought to act on postsynaptic dopamine receptors in brain, mimicking effect of dopamine
|
|
|
Term
Uses of the non-ergot dopamine receptor agonists |
|
Definition
- Parkinson's
- apomorphine is used for "on-off" phenomenon and must be given with an antiemetic
|
|
|
Term
Adverse reactions of the non-ergot dopamine receptor agonists |
|
Definition
- pramipexole and ropinirole (apomorphine not included)
- N/V, dizziness
- Insomnia
- somnolence, hallucinations, confusion, visual disturbances
- postural hypotension
- abnormal involuntary movements
- headache
- dyspepsia
|
|
|
Term
Contraindications of the non-ergot dopamine receptor agonists |
|
Definition
- safety not established for pregnancy (cat C)
|
|
|
Term
Precautions of the non-ergot dopamine receptor agonists |
|
Definition
- dyskinesia
- ortho hypo
- hepatic or renal impairment
- CV disease
- hx hallucinations or psychosis
|
|
|
Term
Preassessment for admin of antiparkinsonism drug |
|
Definition
a. Hx may be hard to obtain from Parkinson pt bc of mental changes; may question family member, etc
b. Assess symptoms, how long sxs, ADL ability, mental condition (memory, depression, withdrawal, etc.)
c. Physical assessment for baseline
d. Eval neuromuscular status, e.g. tremors, mask-face, gait, speech, etc |
|
|
Term
Ongoing assessment of antiparkinsonism drug |
|
Definition
a. Observe neuromuscular status to evaluate response t odrug
b. Improvement may be slow |
|
|
Term
antiparkinsonism drugs and dosage titration |
|
Definition
a. Optimal response requires adjustments/titration, explain this to pt and family; Report all adverse reactions to help with dosage adjustments |
|
|
Term
Mental changes and antiparkinsonism drug given for extrapyramidal adverse reactions of other drugs |
|
Definition
a. When given to manages adverse reactions to other drugs, antiparkinsonism drugs may worsen mental sxs leading to psychotic event – observe pt’s behavior frequently – if sudden behavioral change, withhold and immediately notify PCP |
|
|
Term
|
Definition
- NURSING ALERT – tolcapone (Tasmar) can cause fatal hepatotoxicity.
- Usually prescribed regular hepatic fnx tests including serum aminotransferase q 2 weeks for first year, and q 8 weeks afterwards.
- Tx DC if aminotransferase is high OR S/S of hepatic failure:
- observe for persistent nausea, fatigue/lethargy, anorexia, jaundice, dark urine, pruritus and RUQ tenderness.
|
|
|
Term
Carbidopa/levodopa and choreiform movements |
|
Definition
a. for carbidopa/levodopa admin, watch for CHOREIFORM and dystonic movements such as facial grimacing, protruding tongue, exaggerated chewing, jerking of extremities. If these occur, withhold dose and immediately notify PCP bc drug may need reduction of DC. |
|
|
Term
|
Definition
- ON-OFF PHENOMENON can occur with LEVODOPA.
- Sudden change from improvement to loss of tx effect.
- Associated with long term levodopa use.
- Sometimes, PCP orders a “drug holiday,” where pt is completely w/drawn from levodopa for 5-14 days and gradually restarted at lower dose
- Must monitor for COMPLICATIONS OF LEVODOPA WITHDRAWAL, which can be severe
|
|
|
Term
COMPLICATIONS OF LEVODOPA WITHDRAWAL |
|
Definition
a. AbruptDC of antiparkinsonism drugs is bad. Can cause a “neuroleptic malignant-like syndrome,” including (watch for) muscle rigidity, high temp, mental changes. |
|
|
Term
Re: antiparkinsonism drug admin:
“Imbalanced Nutrition: Less Than Body Requirements rt nausea, dry mouth" |
|
Definition
a. Help with dry mouth by suggesting sipping water, ice, hard candy if allowed.
b. If very severe dry mouth w/ difficulty swallowing or speaking, or if loss of appetite, dosage may need reduction (so report to PCP)
c. Some have N/V and/or constipation which can affect nutrition. So, small frequent meals, caml environment, and serve preferred food to help eat. Also weigh daily. Sometimes helped by giving med with food.
d. Severe N/V may require DC or changing drug, although nausea usually decreases or resolves over time |
|
|
Term
Re: antiparkinsonism drug admin:
“Risk for Injury rt dizziness, lightheadedness, orthostatic hypotension, loss of balance” |
|
Definition
a. Parkinson’s alone caused problems with ambulation; with drugs can exacerbate:
b. Antipark. drugs may cause blurry vision and diplopia (double vision)
c. Report evidence of visual disturbance to PCP (pt may not verbalize problem)
d. Also watch for sudden behavioral changes and report – hallucinations, depression, psychotic episodes
e. Hallucinations more common with elderly taking antipark. drugs, esp. dopamine receptor agonists. Assess older adults for hallucinations
f. Adverse reactions of dizziness, muscle weakness and ataxia can worsen ambulation difficulty
g. Parkinson pts prone to falls, good to help ambulate and encourage assistive devices like cane or walker, gripping shoes, good lighting, no throw rugs – carefully assess environment for obstacles, etc.
h. Ortho hyp may result from drug tx – instruct accordingly (rise slowly, etc) |
|
|
Term
Education re: antiparkinsonism drug admin |
|
Definition
a. evaluate pt’s understanding regimen, self-care ability, ability to comply. If needs assistance, refer to social worker.
b. Home environment should be set up to reduce likelihood of falling, e.g no throw rugs, hand rails,etc.
c. For GI upset, take with food.
d. Avoid hazardous tasks w/ dizziness, drowsiness, vision problems, etc
e. Avoid alcohol unless approved
f. If dry mouth interferes with dentures, consult dentist
g. Ortho hypo teaching
h. Dry mouth teaching
i. When to notify PCP
i. severe dry mouth
ii. inability to chew or swallow
iii. can’t urinate
iv. depression, mood alterations
v. severe dizziness
vi. rapid or irregular heartbeat
vii. ab pain
viii. unusual movements
ix. For levodopa, avoid B6 (pyridoxine) bc can interfere with action
x. For diabetics taking levodopa, levodopa can cause inaccurate glucose and ketone testing, first report abnormal result to PCP (don’t alter doses of antidiabetic)
j. For talcapone, especially important to keep appointments to test liver frequently; report any signs of liver failure, including persistent nausea, fatigue/lethargy, anorexia, jaundice, dark urine, pruritus and RUQ tenderness. |
|
|
Term
Levodopa and diabetes testing |
|
Definition
For diabetics taking levodopa, levodopa can cause inaccurate glucose and ketone testing, first report abnormal result to PCP (don’t alter doses of antidiabetic) |
|
|
Term
What drugs are included in the one combo antiparkinsonism drug listed? And what is it's trade name? |
|
Definition
levodopa + carbidopa + entacapine = Stalevo |
|
|
Term
|
Definition
COMT inhibitor portion is entacapone, precautions are:
- tachydardia
- cardiac arrhythmias
- hyper/hypo tension
- tendency towards urinary retention
- decreased liver or kidney function
- obstructive disease of GI tract
- older adults
dopaminergic portion is levodopa, precautions are
- cv disease
- pulmonary disease
- peptic ulcer
- renal or hepatic disease
- psychosis
- pregnancy and lactation (cat C)
|
|
|
Term
Action and use of carbidopa |
|
Definition
Carbidopa has no effect alone
It is given with levodopa to increase amount of levodopa that reaches the brain
Levodopa alone doesn't cross BB barrier easily, and stays in periphery with adverse reactions
Carbidopa helps levodopa get to brain, therefore reducing dose of levodopa |
|
|
Term
Source of levodopa and action in the body? |
|
Definition
plant and animal derived
converted into dopamine in body
only small amount cross BB barrier (carbidopa increases this) |
|
|
Term
ACHALASIA
With drug is contraindicated with this condition? |
|
Definition
- difficulty swallowing from lower esoph. muscles not relaxing
- anticholinergics are contraindicated in those with achalasia
|
|
|
Term
|
Definition
- for carbidopa/levodopa admin, watch for CHOREIFORM and dystonic movements such as facial grimacing, protruding tongue, exaggerated chewing, jerking of extremities. If these occur, withhold dose and immediately notify PCP bc drug may need reduction of DC.
- ABNORMAL MOVEMENTS
|
|
|
Term
|
Definition
a. Sometimes, PCP orders a “drug holiday,” where pt is completely w/drawn from levodopa for 5-14 days and gradually restarted at lower dose – MUST MONITOR FOR COMPLICATIONS:
b. NURSING ALERT – AbruptDC of antiparkinsonism drugs is bad. Can cause a “neuroleptic malignant-like syndrome,” including (watch for) muscle rigidity, high temp, mental changes. |
|
|
Term
What to watch for if levodopa discontinued? |
|
Definition
Abrupt DC of antiparkinsonism drugs is bad. Can cause a “neuroleptic malignant-like syndrome,” including (watch for) muscle rigidity, high temp, mental changes. |
|
|
Term
What type of drug is tolcapone? |
|
Definition
A COMT inhibitor antiparkinsonism drug |
|
|
Term
Drug that is used to control "on-off" phenomenon? |
|
Definition
apomorphine (Apokyn)
a dopamine receptor agonist |
|
|
Term
levodopa and pyridoxine (B6) |
|
Definition
pyridoxine (B6) decreases effect of levodopa
Does not effect ACTION of levodopa if given with carbidopa)
B6 sometimes prescribed to lessen adv rxns (not action?) of levodopa |
|
|
Term
Anticholinergics and the elderly |
|
Definition
more sensitive to anticholinergics
carefully monitor
more confusion and disorientation
may need lower doses |
|
|
Term
Antiparkinsonism drugs, elderly and hallucinations |
|
Definition
Elderly more prone to hallucinations with antipark drugs
Especially with dopamine receptor agonists |
|
|
Term
dopinergics and tricyclcs |
|
Definition
increased risk of hyptertension and dyskinesia |
|
|
Term
|
Definition
increases effect of levodopa |
|
|
Term
levodopa and anticonvulsants |
|
Definition
decreased effect of levodopa |
|
|
Term
levodopa and the blood brain barrier |
|
Definition
levodopa only crosses in small amounts
carbidopa helps more cross BB barrier |
|
|
Term
|
Definition
increases risk of toxicity of both |
|
|
Term
COMT inhibitor and adrenergic drugs |
|
Definition
increases risk of cardiac symtoms |
|
|
Term
anticholinergic with amantadine |
|
Definition
increases anti-cholinergic effects |
|
|
Term
anticholinergic with digoxin |
|
Definition
increases serum digoxin levels |
|
|
Term
anticholinergic with haloperidol |
|
Definition
increases psychotic behavior |
|
|
Term
anticholinergic and phenothiazines |
|
Definition
increases anticholinergic effects |
|
|
Term
|
Definition
- catechol-O-methyl transferase
- An enzyme involved in NT degradation
- For parkinson's, prevents breakdown of dopamine
|
|
|
Term
AMANTADINE
What type of drug is it? |
|
Definition
A dopinergic drug used for Parkinson's and extrapyramidal syndromes |
|
|
Term
BROMOCRIPTINE
What kind of drug and what used for? |
|
Definition
A dopinergic used for Parkinson's and female endocrine imbalances |
|
|
Term
RASAGILINE
SELEGILINE
What class of drugs are these? |
|
Definition
MAOI dopiminergics for Parkinson's |
|
|
Term
Signs of phenytoin toxicity |
|
Definition
slurred speech
ataxia
lethargy
dizziness
N/V |
|
|
Term
non-ergot dopamine receptor agonists and CNS depressants |
|
Definition
increased risk of CNS depression |
|
|
Term
non-ergot dopamine receptor agonists and levodopa |
|
Definition
increases effect of levodopa, increasing risk of hallucinations |
|
|
Term
non-ergot dopamine receptor agonists and ciprofloxacin |
|
Definition
increases effect of non-ergot dopamine receptor agonists |
|
|
Term
non-ergot dopamine receptor agonists and cimetidine |
|
Definition
increases action of non-ergot dopamine receptor agonists |
|
|
Term
non-ergot dopamine receptor agonists and verapamil |
|
Definition
increases the effect of non-ergot dopamine receptor agonists |
|
|
Term
non-ergot dopamine receptor agonists and quinidine |
|
Definition
increases effect of non-ergot dopamine receptor agonists |
|
|
Term
non-ergot dopamine receptor agonists and estrogen |
|
Definition
increases effect of non-ergot dopamine receptor agonists |
|
|
Term
non-ergot dopamine receptor agonists and phentiazines |
|
Definition
decreases the effect of non-ergot dopamine receptor agonists |
|
|
Term
|
Definition
An anticholinergic used for parkinson's |
|
|
Term
|
Definition
An anticholinergic used for parkinson's |
|
|
Term
|
Definition
An anticholinergic used for parkinson's |
|
|
Term
|
Definition
An anticholinergic used for parkinson's |
|
|
Term
|
Definition
non-ergot dopamine receptor agonist |
|
|
Term
|
Definition
non-ergot dopamine receptor agonist |
|
|
Term
|
Definition
non-ergot dopamine receptor agonist
Used to contol on-off syndrome |
|
|
Term
How often is tolcapone monitored for toxicity? |
|
Definition
q 2 weeks first year
q 8 weeks afterwards |
|
|
Term
What is apomorphine used for and what must it be administered with? |
|
Definition
For on-off phenom of levodopa in parkinson's
Must be given with an anti-emetic |
|
|
Term
If a pt taking levodopa has chorieform movements, what is the nurse to do? |
|
Definition
Withhold and report immediately |
|
|
Term
what kind of drugs are entacapone and tolcapone? |
|
Definition
|
|
Term
When pt should report antiparkinson drug adverse effects |
|
Definition
- severe dry mouth
- inability to chew or swallow
- can’t urinate
- depression, mood alterations
- severe dizziness
- rapid or irregular heartbeat
- ab pain
- unusual movements
|
|
|